AU Stock MarketDetailed Quotes

LTP LTR Pharma Ltd

Watchlist

1.200
-0.050-4.00%

20min DelayClosing Auction Session Nov 4 15:37 AET

184.56MMarket Cap-24000P/E (Static)

LTR Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

-56.58%3.1M

--3.1M

273.80%7.14M

1,207.90%1.91M

--146.14K

-Cash and cash equivalents

-56.58%3.1M

--3.1M

273.80%7.14M

1,207.90%1.91M

--146.14K

Receivables

--265.16K

----

-Other receivables

--265.16K

----

Other current assets

----

49.72%64.82K

--43.3K

----

Total current assets

-53.29%3.37M

--3.37M

268.83%7.21M

1,237.52%1.95M

--146.14K

Non current assets

Net PPE

--1.68K

----

-Gross PPE

--1.68K

----

Non current accounts receivable

----

3.27%300.18K

5.21%290.68K

--276.29K

Other non current assets

----

--270

Total non current assets

-99.44%1.68K

--1.68K

3.27%300.18K

5.11%290.68K

--276.56K

Total assets

-55.14%3.37M

--3.37M

234.45%7.51M

431.20%2.25M

--422.7K

Liabilities

Current liabilities

Current debt and capital lease obligation

----

--359.5K

-Current debt

----

--359.5K

Payables

2,053.02%242.41K

--242.41K

-97.58%11.26K

46,490.60%465.91K

--1K

-accounts payable

2,053.02%242.41K

--242.41K

-97.58%11.26K

46,490.60%465.91K

--1K

Other current liabilities

1,761.35%186.14K

--186.14K

0.00%10K

-90.29%10K

--103K

Current liabilities

1,915.82%428.54K

--428.54K

-95.53%21.26K

2.68%475.91K

--463.5K

Non current liabilities

Total non current liabilities

--0

Total liabilities

1,915.82%428.54K

--428.54K

-95.53%21.26K

2.68%475.91K

--463.5K

Shareholders'equity

Share capital

-0.29%10.74M

--10.74M

285.83%10.77M

--2.79M

----

-common stock

-0.29%10.74M

--10.74M

285.83%10.77M

--2.79M

----

Retained earnings

-145.38%-9.48M

---9.48M

-261.67%-3.86M

-2,517.27%-1.07M

---40.8K

Gains losses not affecting retained earnings

190.66%1.67M

--1.67M

1,185.48%576.24K

--44.83K

----

Total stockholders'equity

-60.73%2.94M

--2.94M

323.20%7.49M

4,436.61%1.77M

---40.8K

Total equity

-60.73%2.94M

--2.94M

323.20%7.49M

4,436.61%1.77M

---40.8K

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	-56.58%3.1M	--3.1M	273.80%7.14M	1,207.90%1.91M	--146.14K
-Cash and cash equivalents	-56.58%3.1M	--3.1M	273.80%7.14M	1,207.90%1.91M	--146.14K
Receivables	--265.16K	--265.16K	----	----	----
-Other receivables	--265.16K	--265.16K	----	----	----
Other current assets	----	----	49.72%64.82K	--43.3K	----
Total current assets	-53.29%3.37M	--3.37M	268.83%7.21M	1,237.52%1.95M	--146.14K
Non current assets
Net PPE	--1.68K	--1.68K	----	----	----
-Gross PPE	--1.68K	--1.68K	----	----	----
Non current accounts receivable	----	----	3.27%300.18K	5.21%290.68K	--276.29K
Other non current assets	----	----	----	----	--270
Total non current assets	-99.44%1.68K	--1.68K	3.27%300.18K	5.11%290.68K	--276.56K
Total assets	-55.14%3.37M	--3.37M	234.45%7.51M	431.20%2.25M	--422.7K
Liabilities
Current liabilities
Current debt and capital lease obligation	----	----	----	----	--359.5K
-Current debt	----	----	----	----	--359.5K
Payables	2,053.02%242.41K	--242.41K	-97.58%11.26K	46,490.60%465.91K	--1K
-accounts payable	2,053.02%242.41K	--242.41K	-97.58%11.26K	46,490.60%465.91K	--1K
Other current liabilities	1,761.35%186.14K	--186.14K	0.00%10K	-90.29%10K	--103K
Current liabilities	1,915.82%428.54K	--428.54K	-95.53%21.26K	2.68%475.91K	--463.5K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0
Total liabilities	1,915.82%428.54K	--428.54K	-95.53%21.26K	2.68%475.91K	--463.5K
Shareholders'equity
Share capital	-0.29%10.74M	--10.74M	285.83%10.77M	--2.79M	----
-common stock	-0.29%10.74M	--10.74M	285.83%10.77M	--2.79M	----
Retained earnings	-145.38%-9.48M	---9.48M	-261.67%-3.86M	-2,517.27%-1.07M	---40.8K
Gains losses not affecting retained earnings	190.66%1.67M	--1.67M	1,185.48%576.24K	--44.83K	----
Total stockholders'equity	-60.73%2.94M	--2.94M	323.20%7.49M	4,436.61%1.77M	---40.8K
Total equity	-60.73%2.94M	--2.94M	323.20%7.49M	4,436.61%1.77M	---40.8K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data